Hemodilution and coagulation: An overview

Minerva Anestesiologica

Volumn 68, Issue 4, 2002, Pages 178-181

  Hobisch Hagen, P ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Blood coagulation; Blood coagulation disorders; Colloids; Plasma substituces

Indexed keywords

PLASMA SUBSTITUTE;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COLLOID; HEMODILUTION; HEMOSTASIS; HUMAN; PERIOPERATIVE PERIOD; REVIEW; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE; DRUG EFFECT; PHYSIOLOGY;

BLOOD COAGULATION; HEMODILUTION; HEMOSTASIS; HUMANS; PLASMA SUBSTITUTES;

EID: 0036545921     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Sakamoto R, Nagle SE. Massive transfusion. Probl Anesth 1990;5:444-58.
2. Yeston NS, Dobkin ED. Transfusion therapy. Probl Anesth 1989;3:228.
3. Stehling LC. A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice Guidelines for Blood Component Therapy. Anesthesiology 1996;84:732-47.
4. Innerhofer P, Luz G, Spötl P, Hobisch-Hagen P, Scobersberger W, Fischer M et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T-cells. Transfusion 1999;39:1089-96.
5. Innerhofer P, Tilz G, Fuchs D, Luz G, Hobisch-Hagen P, Scobersberger W et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T-cells, macrophages and cell-mediated lympholysis. Transfusion 2000;40:821-7.
6. Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stockl B et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999;39:625-32.
7. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988;28:257-60.
8. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997;78:947-83.
9. Ruttman TG, James MFM, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5%) and normal saline on coagulation. Br J Anaesth 1998;80:612-6.
10. Hobisch-Hagen P, Wirleitner B, Mair J, Luz G, Innerhofer P, Frischhut B et al. Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery. Br J Anaesth 1999;82:503-509
11. Iselin BM, Willimann PFX, Seifert B, Casutt M, Bombeli T, Zalunardo MP et al. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth 2001;87:246-9.
12. Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. An in vitro thrombelastography study. Br J Anaesth 1997;78:684-9.
13. Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L et al. Reduced quality of clot formation with gelatin based plasma substitutes. Br J Anaesth 1998;80:204-7.
14. Engvall E, Roslahti E, Miller EJ. Affinity of fibronectin to collagens of different genetic types and fibrinogen. J Exp Med 1978;147:1584-95.
15. de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998;79:286-90.
16. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayer M, Calatzis A et al. The effect of the combined administration of colloids and lactated Ringers's solution on the coagulation system: an in vitro study using Thromboelastograph® coagulation analysis (ROTEG®). Anesth Analg 2002, in press.
17. Petroianu GA, Liu J Maleck WH, Mattinger C, Bergler WF. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch or Ringer's solution on thrombelastograph. Anesth Analg 2000;90(4):795-800.
18. Langeren O, Doelbrg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven®, a lower substituted novel hydroxyethyl starch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/05. Anesth Analg 2001;92:855-65.
19. Entholzer EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR. Coagulation effects of a recently developed hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000;44:1116-21.
20. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR et al. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/04 an hydroxyethyl starch 200/0.5 using thromboelastography. Anesth Analg 1998;87:989-93.
21. Treib J, Haass A, Pindur G, Graver MT, Wenzel E, Schimrigk K. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996;36:450-5.
22. Conroy J, Fishman R, Reeves S, Pinosky ML, Lazarchick J. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII: C. Anesth Analg 1996;83:804-80.
23. Kapiotis S, Quenhenberger P, Eichler H, Schwarzinger I, Partan C, Schneider B et al. Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 1994;22:606-12.
24. Engelmann L, Pilz U, Gundelach K. Akute elementare Effekte der kolloidalen Plasmaersatzmittel Infukoll HES 10%, Gelofusal-N und Infukoll M40 (Dextran) bei Patienten mit Sepsis. J Anaesth Intensiv Med 1997;3:39-46.
25. Stögermüller B, Stark J, Willschke H, Felfernig Michael, Hoerauf K, Kozek-Langenecker SA. The effect of Hydroxyethyl starch 200 KD on platelet function. Anesth Analg 2000;91:823-7.
26. Ruttmann TG, James MFM, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996;76:412-4.
27. Janvrin SB, Davies G, Greenhalgh RM. Postoperative deep vein thrombosis caused by intravenous fluids during surgery. Br J Surg 1980;67:690-3.
28. Monkhouse FC. Relationship between antithrombin and thrombinlevels in plasma and serum. Am J Physiol 1959;197:984-8.